Treatment of endometriosis with a decreasing dosage of a gonadotropin-releasing hormone agonist (nafarelin): a pilot study with low-dose agonist therapy (''draw-back'' therapy)

By Tahara M.   Matsuoka T.   Yokoi T.   Tasaka K.   Kurachi H.   Murata Y.  

Fertility and Sterility, Vol. 73, Iss. 4, 2000-04 ,pp. : 799-804

Elsevier

Access to resources Recommend Favorite

Sperm to zona pellucida binding depends on the use of a gonadotropin-releasing hormone agonist or a gonadotropin-releasing hormone antagonist

By Schroder A.K.   Schopper B.   Al-Hasani S.   Loning M.   Diedrich K.   Ludwig M.  

Fertility and Sterility, Vol. 79, Iss. 3, 2003-03 ,pp. : 648-650

Elsevier

Access to resources Recommend Favorite

Comparison of a single half-dose, long-acting form of gonadotropin-releasing hormone analog (GnRH-a) and a short-acting form of GnRH-a for pituitary suppression in a controlled ovarian hyperstimulation program

By Hsieh Y.-Y.   Tsai H.-D.   Chang C.-C.   Chang C.-C.   Lo H.-Y.  

Fertility and Sterility, Vol. 73, Iss. 4, 2000-04 ,pp. : 817-820

Elsevier

Access to resources Recommend Favorite

Long-term use of gonadotropin-releasing hormone analogs and hormone replacement therapy in the management of endometriosis: a randomized trial with a 6-year follow-up

By Pierce S.J.   Gazvani M.R.   Farquharson R.G.  

Fertility and Sterility, Vol. 74, Iss. 5, 2000-11 ,pp. : 964-968

Elsevier

Access to resources Recommend Favorite

Two rare events in one patient undergoing assisted conception: empty follicle syndrome and ovarian hyperstimulation with the sole administration of a gonadotropin-releasing hormone agonist - low-dose side effects in women and monkeys

By Khalaf Y.   Anderson H.   Taylor A.   Braude P.  

Fertility and Sterility, Vol. 73, Iss. 1, 2000-01 ,pp. : 171-172

Elsevier

Access to resources Recommend Favorite